The role of TNFR2+ Tregs in COVID-19: An overview and a potential therapeutic strategy

被引：12
|
作者：
Ahmad, Suhana [1 ]
Hatmal, Ma'mon M. [2 ]
Lambuk, Lidawani [1 ]
Al-Hatamleh, Mohammad A., I [1 ]
Alshaer, Walhan [3 ]
Mohamud, Rohimah [1 ]
机构：
[1] Univ Sains Malaysia, Sch Med Sci, Dept Immunol, Kubang Kerian 16150, Kelantan, Malaysia
[2] Hashemite Univ, Fac Appl Hlth Sci, Dept Med Lab Sci, POB 330127, Zarqa 13133, Jordan
[3] Univ Jordan, Cell Therapy Ctr CTC, Amman 11942, Jordan
来源：
LIFE SCIENCES | 2021年 / 286卷
关键词：
TNF-TNFR2; SARS-CoV-2; Immunotherapy; Immune tolerance; TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; NF-KAPPA-B; TNF-ALPHA; RECEPTOR; IMMUNE-RESPONSE; EXPRESSION; PHENOTYPE; MACROPHAGES; SUPPRESSION;
D O I：
10.1016/j.lfs.2021.120063
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
COVID-19 is a multi-faceted disease ranging from asymptomatic to severely ill condition that primarily affects the lungs and could advance to other organs as well. It's causing factor, SARS-CoV-2 is recognized to develop robust cell-mediated immunity that responsible to either control or exaggerate the infection. As an important cell subset that control immune responses and are significantly dysregulated in COVID-19, Tregs is proposed to be considered for COVID-19 management. Among its hallmark, TNFR2 is recently recognized to play important role in the function and survival of Tregs. This review gathers available TNFR2 agonists to directly target Tregs as a potential approach to overcome immune dysregulation that affect the severity in COVID-19. Furthermore, this review performs a rigid body docking of TNF-TNFR2 interaction and such interaction with TNFR2 agonist to predict the optimal targeting approach.
引用
收藏
页数：8
相关论文
共 50 条
  • [21] ACE2 as a potential therapeutic target for pandemic COVID-19
    Chatterjee, Bhaswati
    Thakur, Suman S.
    RSC ADVANCES, 2020, 10 (65) : 39808 - 39813
  • [22] Potential immunomodulatory role of sesamin in combating immune dysregulation associated with COVID-19
    Majdalawieh, Amin F.
    Yousef, Sarah M.
    Abu-Yousef, Imad A.
    ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, 2021, 11 (10) : 421 - 428
  • [23] Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV
    Zheng, Wenjiang
    Wu, Hui
    Wang, Ting
    Zhan, Shaofeng
    Liu, Xiaohong
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (06)
  • [24] Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19
    Cheema, Pradeep Singh
    Nandi, Deeptashree
    Nag, Alo
    OPEN BIOLOGY, 2021, 11 (06)
  • [25] PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
    Lugnier, Claire
    Al-Kuraishy, Hayder M.
    Rousseau, Eric
    BIOCHEMICAL PHARMACOLOGY, 2021, 185
  • [26] HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
    Ripamonti, Chiara
    Spadotto, Valeria
    Pozzi, Pietro
    Stevenazzi, Andrea
    Vergani, Barbara
    Marchini, Mattia
    Sandrone, Giovanni
    Bonetti, Emanuele
    Mazzarella, Luca
    Minucci, Saverio
    Steinkuehler, Christian
    Fossati, Gianluca
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Overview of the pathogenesis of COVID-19 (Review)
    Li, Chao
    He, Qifang
    Qian, Hebu
    Liu, Jun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (03)
  • [28] Monoclonal Antibodies as Potential COVID-19 Therapeutic Agents
    Plichta, Jacek
    Kuna, Piotr
    Panek, Michal
    COVID, 2022, 2 (05): : 599 - 620
  • [29] A20 as a Potential Therapeutic Target for COVID-19
    Wu, Yongyao
    He, Lilan
    Li, Rong
    Li, Jiuxuan
    Zhao, Qing
    Shao, Bin
    IMMUNITY INFLAMMATION AND DISEASE, 2025, 13 (01)
  • [30] Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy
    Aoe, Tomohiko
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345